QuantBio Innovations Fund LP is a hedge fund based in New York, New York. According to its most recent Form D, filed May 5, 2025, the fund has sold $4,401,000 of interests to 15 investors since its first sale in May 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Jean-Pierre Naegeli; Andrew Rubinstein.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $4,401,000Cumulative sales reported on Form D
- Investors
- 15
- First sale
- May 9, 2022
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Jean-Pierre Naegeli; Andrew Rubinstein
- Latest Form D
- May 5, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about QuantBio Innovations Fund LP
What is the minimum investment for QuantBio Innovations Fund LP?
QuantBio Innovations Fund LP's latest Form D, filed May 5, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in QuantBio Innovations Fund LP?
QuantBio Innovations Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has QuantBio Innovations Fund LP raised?
QuantBio Innovations Fund LP reports $4,401,000 sold from 15 investors on its Form D filed May 5, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is QuantBio Innovations Fund LP based?
QuantBio Innovations Fund LP is based in New York, New York.
When did QuantBio Innovations Fund LP launch?
QuantBio Innovations Fund LP reports its first sale in May 2022, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every hedge fund
Raised more than 18% of the 2,544 hedge funds based in New York, and more than 14% of all 10,307 that report sales.